Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2017, Article ID 3851262, 15 pages
https://doi.org/10.1155/2017/3851262
Research Article

Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies

1Department of Molecular Neurology, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
2Department of Cellular and Molecular Medicine, University of California, La Jolla, San Diego, CA, USA
3Departments of Neurosciences and Pathology, University of California, La Jolla, San Diego, CA, USA
4Department of Neuropathology, Regensburg University Hospital, 93053 Regensburg, Germany

Correspondence should be addressed to Jürgen Winkler; ed.negnalre-ku@relkniw.negreuj and Eliezer Masliah; ude.dscu@hailsame

Received 3 August 2016; Revised 24 November 2016; Accepted 28 December 2016; Published 19 March 2017

Academic Editor: Long-Jun Wu

Copyright © 2017 Zacharias Kohl et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Devanand, K. S. Michaels-Marston, X. Liu et al., “Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up,” The American Journal of Psychiatry, vol. 157, no. 9, pp. 1399–1405, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Doty, “Olfaction in Parkinson's disease and related disorders,” Neurobiology of Disease, vol. 46, no. 3, pp. 527–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Magerova, M. Vyhnalek, J. Laczo et al., “Odor identification in frontotemporal lobar degeneration subtypes,” American Journal of Alzheimer's Disease and other Dementias, vol. 29, no. 8, pp. 762–768, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Pardini, E. D. Huey, A. L. Cavanagh, and J. Grafman, “Olfactory function in corticobasal syndrome and frontotemporal dementia,” Archives of Neurology, vol. 66, no. 1, pp. 92–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Paulsen, D. R. Langbehn, J. C. Stout et al., “Detection of Huntington's disease decades before diagnosis: The Predict-HD Study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 8, pp. 874–880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Babizhayev, A. I. Deyev, and Y. E. Yegorov, “Olfactory dysfunction and cognitive impairment in age-related neurodegeneration: prevalence related to patient selection, diagnostic criteria and therapeutic treatment of aged clients receiving clinical neurology and community-based care,” Current Clinical Pharmacology, vol. 6, no. 4, pp. 236–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. W. Ross, H. Petrovitch, R. D. Abbott et al., “Association of olfactory dysfunction with risk for future Parkinson's disease,” Annals of Neurology, vol. 63, no. 2, pp. 167–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Attems, L. Walker, and K. A. Jellinger, “Olfactory bulb involvement in neurodegenerative diseases,” Acta Neuropathologica, vol. 127, no. 4, pp. 459–475, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kovács, N. J. Cairns, and P. L. Lantos, “Olfactory centres in alzheimer's disease: olfactory bulb is involved in early braak's stages,” NeuroReport, vol. 12, no. 2, pp. 285–288, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Braak, K. Del Tredici, U. Rüb, R. A. I. De Vos, E. N. H. Jansen Steur, and E. Braak, “Staging of brain pathology related to sporadic Parkinson's disease,” Neurobiology of Aging, vol. 24, no. 2, pp. 197–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Funabe, M. Takao, Y. Saito et al., “Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa,” Neuropathology, vol. 33, no. 1, pp. 47–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. I.-C. Mundiñano, M.-C. Caballero, C. Ordóñez et al., “Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders,” Acta Neuropathologica, vol. 122, no. 1, pp. 61–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Takeda, M. Iijima, T. Uchihara et al., “TDP-43 pathology progression along the olfactory pathway as a possible substrate for olfactory impairment in amyotrophic lateral sclerosis,” Journal of Neuropathology and Experimental Neurology, vol. 74, no. 6, pp. 547–556, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. V. H. Perry and C. Holmes, “Microglial priming in neurodegenerative disease,” Nature Reviews Neurology, vol. 10, no. 4, pp. 217–224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Lambert, C. A. Ibrahim-Verbaas, D. Harold et al., “Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease,” Nature Genetics, vol. 45, no. 12, pp. 1452–1458, 2013. View at Publisher · View at Google Scholar
  16. T. H. Hamza and H. Payami, “The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors,” Journal of Human Genetics, vol. 55, no. 4, pp. 241–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Ferrari, D. G. Hernandez, M. A. Nalls et al., “Frontotemporal dementia and its subtypes: a genome-wide association study,” The Lancet Neurology, vol. 13, no. 7, pp. 686–699, 2014. View at Publisher · View at Google Scholar
  18. Z. Fan, A. A. Okello, D. J. Brooks, and P. Edison, “Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease,” Brain, vol. 138, no. 12, pp. 3685–3698, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gerhard, N. Pavese, G. Hotton et al., “In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease,” Neurobiology of Disease, vol. 21, no. 2, pp. 404–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Doorn, A. Goudriaan, C. Blits-Huizinga et al., “Increased amoeboid microglial density in the Olfactory Bulb of Parkinson's and Alzheimer's Patients,” Brain Pathology, vol. 24, no. 2, pp. 152–165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. G. Torres-Platas, S. Comeau, A. Rachalski et al., “Morphometric characterization of microglial phenotypes in human cerebral cortex,” Journal of Neuroinflammation, vol. 11, article 12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Sanchez-Guajardo, F. Febbraro, D. Kirik, and M. Romero-Ramos, “Microglia acquire distinct activation profiles depending on the degree of α-synuclein neuropathology in a rAAV based model of Parkinson's disease,” PLoS ONE, vol. 5, no. 1, Article ID e8784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Lant, A. C. Robinson, J. C. Thompson et al., “Patterns of microglial cell activation in frontotemporal lobar degeneration,” Neuropathology and Applied Neurobiology, vol. 40, no. 6, pp. 686–696, 2014. View at Publisher · View at Google Scholar
  24. C. Lois, J.-M. García-Verdugo, and A. Alvarez-Buylla, “Chain migration of neuronal precursors,” Science, vol. 271, no. 5251, pp. 978–981, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kosaka, K. Toida, Y. Aika, and T. Kosaka, “How simple is the organization of the olfactory glomerulus?: The heterogeneity of so-called periglomerular cells,” Neuroscience Research, vol. 30, no. 2, pp. 101–110, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Kornack and P. Rakic, “The generation, migration, and differentiation of olfactory neurons in the adult primate brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4752–4757, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Curtis, M. Kam, U. Nannmark et al., “Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension,” Science, vol. 315, no. 5816, pp. 1243–1249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Sanai, T. Nguyen, R. A. Ihrie et al., “Corridors of migrating neurons in the human brain and their decline during infancy,” Nature, vol. 478, no. 7369, pp. 382–386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Wang, F. Liu, Y.-Y. Liu et al., “Identification and characterization of neuroblasts in the subventricular zone and rostral migratory stream of the adult human brain,” Cell Research, vol. 21, no. 11, pp. 1534–1550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. K. Hamilton, A. Aumont, C. Julien, A. Vadnais, F. Calon, and K. J. L. Fernandes, “Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's disease,” European Journal of Neuroscience, vol. 32, no. 6, pp. 905–920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Marxreiter, M. Regensburger, and J. Winkler, “Adult neurogenesis in Parkinson's disease,” Cellular and Molecular Life Sciences, vol. 70, no. 3, pp. 459–473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Lazarini, M.-M. Gabellec, N. Torquet, and P.-M. Lledo, “Early activation of microglia triggers long-lasting impairment of adult neurogenesis in the olfactory bulb,” The Journal of Neuroscience, vol. 32, no. 11, pp. 3652–3664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. K. J. Doorn, B. Drukarch, A.-M. Van Dam, and P. J. Lucassen, “Hippocampal proliferation is increased in presymptomatic parkinson's disease and due to microglia,” Neural Plasticity, vol. 2014, Article ID 959154, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. P. J. Lucassen, M. W. Stumpel, Q. Wang, and E. Aronica, “Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients,” Neuropharmacology, vol. 58, no. 6, pp. 940–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. E. Batchelor, G. T. Liberatore, J. Y. F. Wong et al., “Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor,” The Journal of Neuroscience, vol. 19, no. 5, pp. 1708–1716, 1999. View at Google Scholar · View at Scopus
  36. M. B. Watson, F. Richter, S. K. Lee et al., “Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein,” Experimental Neurology, vol. 237, no. 2, pp. 318–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. P. V. Hoogland and E. Huisman, “Tyrosine hydroxylase immunoreactive structures in the aged human olfactory bulb and olfactory peduncle,” Journal of Chemical Neuroanatomy, vol. 17, no. 3, pp. 153–161, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. S. S. Rabinowitz and S. Gordon, “Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli,” Journal of Experimental Medicine, vol. 174, no. 4, pp. 827–836, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Tsuboi, Z. K. Wszolek, N. R. Graff-Radford, N. Cookson, and D. W. Dickson, “Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4,” Neuropathology and Applied Neurobiology, vol. 29, no. 5, pp. 503–510, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Sengoku, Y. Saito, M. Ikemura et al., “Incidence and extent of lewy body-related α-synucleinopathy in aging human olfactory bulb,” Journal of Neuropathology and Experimental Neurology, vol. 67, no. 11, pp. 1072–1083, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Nishimura, V. Upunski, C. Troakes et al., “Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration,” Brain, vol. 133, no. 6, pp. 1763–1771, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. T. Heneka, M. J. Carson, J. El Khoury et al., “Neuroinflammation in Alzheimer's disease,” The Lancet Neurology, vol. 14, no. 4, pp. 388–405, 2015. View at Google Scholar
  43. K. J. Doorn, P. J. Lucassen, H. W. Boddeke et al., “Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease,” Progress in Neurobiology, vol. 98, no. 2, pp. 222–238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz, “Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease,” Neurology, vol. 69, no. 19, pp. 1836–1842, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Jucaite, P. Svenningsson, J. O. Rinne et al., “Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease,” Brain, vol. 138, no. 9, pp. 2687–2700, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Sasaki, “Microglia and brain macrophages: an update,” Neuropathology, 2016. View at Publisher · View at Google Scholar
  47. D. G. Walker and L.-F. Lue, “Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains,” Alzheimer's Research and Therapy, vol. 7, no. 1, article 56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. D. M. Paresce, R. N. Ghosh, and F. R. Maxfield, “Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor,” Neuron, vol. 17, no. 3, pp. 553–565, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Gomez-Nicola and D. Boche, “Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease,” Alzheimer's Research and Therapy, vol. 7, no. 1, article 42, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. M. M. Ponsen, D. Stoffers, J. Booij, B. L. F. Van Eck-Smit, E. C. Wolters, and H. W. Berendse, “Idiopathic hyposmia as a preclinical sign of Parkinson's disease,” Annals of Neurology, vol. 56, no. 2, pp. 173–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Vroon, B. Drukarch, J. G. J. M. Bol et al., “Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb,” Experimental Gerontology, vol. 42, no. 8, pp. 762–771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. W. J. Streit and Q.-S. Xue, “Microglia in dementia with Lewy bodies,” Brain, Behavior, and Immunity, vol. 55, pp. 191–201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Cagnin, M. Rossor, E. L. Sampson, T. MacKinnon, and R. B. Banati, “In vivo detection of microglial activation in frontotemporal dementia,” Annals of Neurology, vol. 56, no. 6, pp. 894–897, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Kleinberger, Y. Yamanishi, M. Suarez-Calvet et al., “TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis,” Science Translational Medicine, vol. 6, no. 243, p. 243ra86, 2014. View at Publisher · View at Google Scholar
  55. D. Gómez-Nicola, N. L. Fransen, S. Suzzi, and V. Hugh Perry, “Regulation of microglial proliferation during chronic neurodegeneration,” The Journal of Neuroscience, vol. 33, no. 6, pp. 2481–2493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. K. J. Doorn, T. Moors, B. Drukarch, W. D. J. van de Berg, P. J. Lucassen, and A.-M. van Dam, “Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients,” Acta Neuropathologica Communications, vol. 2, article 90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Nacher, R. Guirado, and E. Castillo-Gómez, “Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders,” Neurochemical Research, vol. 38, no. 6, pp. 1122–1133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Wang and H. Neumann, “Alleviation of neurotoxicity by microglial human Siglec-11,” The Journal of Neuroscience, vol. 30, no. 9, pp. 3482–3488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Solano Fonseca, S. Mahesula, D. M. Apple et al., “Neurogenic niche microglia undergo positional remodeling and progressive activation contributing to age-associated reductions in neurogenesis,” Stem Cells and Development, vol. 25, no. 7, pp. 542–555, 2016. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Sierra, J. M. Encinas, J. J. P. Deudero et al., “Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis,” Cell Stem Cell, vol. 7, no. 4, pp. 483–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. P. S. Eriksson, E. Perfilieva, T. Björk-Eriksson et al., “Neurogenesis in the adult human hippocampus,” Nature Medicine, vol. 4, no. 11, pp. 1313–1317, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. K. L. Spalding, O. Bergmann, K. Alkass et al., “Dynamics of hippocampal neurogenesis in adult humans,” Cell, vol. 153, no. 6, pp. 1219–1227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Ekonomou, G. M. Savva, C. Brayne et al., “Stage-specific changes in neurogenic and glial markers in Alzheimer's disease,” Biological Psychiatry, vol. 77, no. 8, pp. 711–719, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Winner, M. Regensburger, S. Schreglmann et al., “Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus,” Journal of Neuroscience, vol. 32, no. 47, pp. 16906–16916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. O. Bergmann, J. Liebl, S. Bernard et al., “The age of olfactory bulb neurons in humans,” Neuron, vol. 74, no. 4, pp. 634–639, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Lazarini, M.-M. Gabellec, C. Moigneu, F. D. Chaumont, J.-C. Olivo-Marin, and P.-M. Lledo, “Adult neurogenesis restores dopaminergic neuronal loss in the olfactory bulb,” The Journal of Neuroscience, vol. 34, no. 43, pp. 14430–14442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Winner, E. Rockenstein, D. C. Lie et al., “Mutant α-synuclein exacerbates age-related decrease of neurogenesis,” Neurobiology of Aging, vol. 29, no. 6, pp. 913–925, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. G. U. Höglinger, P. Rizk, M. P. Muriel et al., “Dopamine depletion impairs precursor cell proliferation in Parkinson disease,” Nature Neuroscience, vol. 7, no. 7, pp. 726–735, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. S. A. van den Berge, M. E. van Strien, J. A. Korecka et al., “The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain,” Brain, vol. 134, no. 11, pp. 3249–3263, 2011. View at Publisher · View at Google Scholar · View at Scopus